Stockreport

PainReform Provides Further Update on Phase 3 Clinical Trial of PRF-110 [Yahoo! Finance]

PainReform Ltd. - Ordinary Shares  (PRFX) 
PDF TEL AVIV, Israel, Dec. 27, 2024 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) (" PainReform " or the " Company "), a clinical-stage specialty pharmaceutical compan [Read more]